Moderate prostatomegaly, 61 y old male with p/r bleeding , pus cells 80 in urine. What can be the diagnosis and management

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Searching PubMed

benign prostatic hyperplasia UTI hematuria management

I now have enough information to provide a thorough answer. Let me compile the full clinical response.

Clinical Analysis: 61-Year-Old Male with Moderate Prostatomegaly, P/R Bleeding, and Pyuria (80 pus cells/HPF)


Differential Diagnosis

This is a multi-system presentation. The key findings - moderate prostatomegaly, per-rectal (PR) bleeding, and significant pyuria (80 pus cells/HPF) - point to the following possibilities, which may coexist:

1. PRIMARY DIAGNOSES (Most Likely)

A. Benign Prostatic Hyperplasia (BPH) with complicated UTI / Acute Bacterial Prostatitis
  • BPH is the commonest cause of prostatomegaly at this age (development of nodules within the prostate beginning in the 4th decade, nearly universal by the 7th decade)
  • Bladder outflow obstruction from BPH causes urinary stasis, which predisposes to bacterial colonisation and UTI
  • 80 pus cells/HPF is a significantly elevated pyuria, consistent with UTI or acute bacterial prostatitis
  • PR bleeding in a man with BPH may represent haemorrhoids (secondary to straining due to obstructive symptoms), or less commonly, direct bleeding from prostatic venous engorgement
  • Sabiston Textbook of Surgery states that surgical indication for BPH includes "recurrent UTI" and "recurrent hematuria"
B. Acute Bacterial Prostatitis
  • Presents with fever, perineal/lower back pain, irritative LUTS, and pyuria
  • The prostate may feel boggy and tender on digital rectal examination (DRE)
  • E. coli is the most common causative organism
  • PR bleeding may accompany manipulation/examination of an inflamed prostate
C. Prostatic Carcinoma (must be excluded)
  • Age 61, enlarged prostate: prostate cancer must be part of the differential
  • Prostate cancer can present with LUTS, haematuria, and sometimes PR bleeding (especially if locally advanced invading the rectum)
  • A hard, irregular, nodular prostate on DRE vs. the firm, smooth, rubbery feel of BPH distinguishes the two - this distinction is clinically essential

2. CONCURRENT / CONTRIBUTORY CONDITIONS

D. Haemorrhoids / Anorectal pathology
  • PR bleeding in a 61-year-old may be from haemorrhoids, anal fissure, or polyps - common in men with constipation or straining from obstructive uropathy
  • Must be distinguished from blood coming from the urethra
E. Bladder pathology
  • Bladder carcinoma (especially in a man this age with haematuria/pyuria) must be ruled out
  • Bladder calculi secondary to chronic urinary retention - can cause infection, haematuria, and irritative symptoms
F. Colorectal malignancy
  • PR bleeding in a 61-year-old mandates exclusion of colorectal cancer - this is independent of the urological picture

Investigations

Urine and Infection Workup:
  • Urine routine/microscopy + urine culture & sensitivity (to identify organism and guide antibiotic therapy)
  • Urine cytology (to exclude transitional cell carcinoma)
Prostate Assessment:
  • PSA (Prostate-Specific Antigen) - essential to screen for prostate cancer; elevated in both BPH and cancer, but markedly elevated or rapidly rising PSA favours malignancy
  • Digital Rectal Examination (DRE) - assess prostate size, consistency, symmetry, tenderness
  • Transrectal Ultrasound (TRUS) - assess prostate volume accurately; can guide biopsy
  • Prostate Biopsy - if PSA elevated or DRE suspicious for malignancy
Bladder and Upper Tract:
  • Ultrasound KUB - assess kidneys, bladder (post-void residual, bladder wall thickness, calculi), and prostate size
  • Uroflowmetry + Post-void residual (PVR) - objective measure of outflow obstruction
  • Cystoscopy - if haematuria persists or bladder pathology suspected
  • CT Urogram - if upper tract pathology or malignancy is suspected
Colorectal:
  • Colonoscopy / Sigmoidoscopy - mandatory to investigate PR bleeding and exclude colorectal malignancy in a 61-year-old
  • Proctoscopy for haemorrhoids
Bloods:
  • CBC (anaemia, infection)
  • Serum creatinine / eGFR (renal function - bladder outflow obstruction can cause obstructive nephropathy)
  • Blood glucose (diabetics are prone to complicated UTI)
  • Coagulation profile if significant bleeding
Symptom Scoring:
  • International Prostate Symptom Score (IPSS) - quantifies LUTS severity and guides management decisions

Management

Step 1: Treat the Active Infection First

Antibiotic therapy for UTI/Bacterial Prostatitis:
  • Fluoroquinolones (ciprofloxacin 500 mg BD or levofloxacin 500 mg OD) are the agents of choice for prostatitis because of excellent prostatic tissue penetration - duration 4-6 weeks for acute bacterial prostatitis
  • If organism is confirmed on culture, tailor to sensitivity
  • Avoid trimethoprim-sulfamethoxazole as increasing resistance
  • Adequate hydration

Step 2: Manage BPH (Medical)

Per the AUA Guideline (2023) referenced in Sabiston:
Alpha-1 Adrenergic Blockers (first-line for LUTS relief):
  • Tamsulosin 0.4 mg OD (or alfuzosin, silodosin)
  • Relax smooth muscle of prostate and bladder neck
  • Rapid symptom relief (within days to weeks)
5-Alpha Reductase Inhibitors (for large prostates):
  • Finasteride 5 mg OD or Dutasteride 0.5 mg OD
  • Reduce prostate volume by 20-30% over 3-6 months
  • Reduce PSA by ~50% (important to interpret PSA accordingly)
  • Indicated when prostate is enlarged; also reduce risk of acute urinary retention and need for surgery
  • Both drugs can be combined for superior results compared to monotherapy alone (Sabiston Textbook of Surgery, p. 2825)
Behavioural modifications:
  • Restrict evening fluid intake
  • Avoid caffeine and alcohol
  • Timed voiding

Step 3: Surgical Management (if indicated)

Indications for surgery include (Sabiston Textbook of Surgery, p. 2825):
  • Acute urinary retention
  • Bladder calculi
  • Azotaemia (obstructive renal failure)
  • Recurrent UTI
  • Recurrent haematuria
  • Medical therapy failure
Standard surgical option: TURP (Transurethral Resection of the Prostate) - improves IPSS, flow rate, and PVR dramatically. Newer bipolar/laser TURP eliminates dilutional hyponatremia risk.
For very large prostates: Open simple prostatectomy or HoLEP (Holmium Laser Enucleation of the Prostate)
Minimally invasive options (office setting): Microwave thermotherapy, radiofrequency ablation - though long-term outcomes inferior to TURP.

Step 4: Address PR Bleeding Separately

  • Sigmoidoscopy/colonoscopy to exclude colorectal cancer - this is independent, urgent workup in a 61-year-old
  • If haemorrhoids: conservative management (fibre, stool softeners, topical agents); banding/surgical haemorrhoidectomy if severe
  • If bleeding appears to be post-TRUS biopsy or from a prostatic origin: usually self-limiting, managed with direct pressure; persistent bleeding may need intervention (Campbell Walsh Wein Urology)

Summary Table

IssueAction
Pyuria (80 cells/HPF)Urine C&S + fluoroquinolone (4-6 wks if prostatitis)
ProstatomegalyPSA, DRE, TRUS, IPSS scoring
BPH (if confirmed)Alpha-blocker + 5-ARI; surgery if indications met
PR bleedingProctoscopy + colonoscopy to exclude colorectal Ca
Prostate Ca suspicionPSA + TRUS biopsy
Renal functionUltrasound + serum creatinine

Key Clinical Pearls

  • Do not miss prostate cancer - moderate prostatomegaly with LUTS at age 61 requires PSA and DRE before attributing everything to BPH
  • PR bleeding in a 61-year-old is colorectal cancer until proven otherwise - urological and colorectal workup must run in parallel
  • Treat the infection before planning BPH surgery - operating on an infected prostate carries significant risk
  • PSA must be checked before DRE/TRUS biopsy (examination can falsely elevate PSA), and results interpreted knowing that 5-ARIs halve PSA values
Sources: Sabiston Textbook of Surgery (BPH, pp. 2821-2826); Campbell Walsh Wein Urology (Prostate Biopsy Complications, Prostate Cancer Diagnosis); AUA BPH Guideline 2023 (via Sandhu JS et al., J Urol 2024;211[1]:11-19)

Moderate prostatomegaly, 61 y old male with p/r bleeding , pus cells 80 in urine. What can be the diagnosis and management

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
I now have comprehensive textbook data. Let me compile the full answer.

Clinical Assessment: 61-Year-Old Male | Moderate Prostatomegaly + PR Bleeding + Pyuria (80 pus cells/HPF)


DIFFERENTIAL DIAGNOSIS

This triad overlaps three distinct pathological processes that must each be addressed:

1. Benign Prostatic Hyperplasia (BPH) with Complicated UTI / Acute Bacterial Prostatitis

Most likely primary diagnosis.
BPH develops in approximately 50% of men older than 50 years and 90% by their 80s. At 61 years, the prostate volume typically ranges 24-38 mL, and volumes exceeding 30 mL define prostatomegaly. BPH causes bladder outlet obstruction (BOO), which creates urinary stasis - the single biggest risk factor for ascending bacterial infection and UTI. (Goldman-Cecil Medicine, Ch. 114)
Pyuria of 80 cells/HPF is far above the threshold of >5 cells/HPF that defines significant pyuria, strongly indicating:
  • Urinary tract infection (UTI) secondary to obstructive stasis, or
  • Acute bacterial prostatitis - the 3rd most common urologic diagnosis in men over 50
In acute bacterial prostatitis, infection ascends from the urethra or refluxes from infected bladder urine into prostatic ducts. Leukocytes (PMNs, lymphocytes, macrophages) appear within and surrounding prostatic acini. The prostate becomes edematous, hyperemic, and tender - feeling "boggy and warm" on DRE. PSA is typically elevated during acute infection. E. coli is the most common causative organism; Klebsiella, Proteus, Pseudomonas, Enterococcus less so. (Smith & Tanagho's General Urology, Ch. 14)
PR bleeding in this context may arise from:
  • Haemorrhoids - very common in men with obstructive voiding symptoms who strain at micturition
  • Prostatic venous congestion and engorgement
  • (Importantly: must be distinguished from haematuria/urethral bleeding)

2. Prostate Carcinoma (must be excluded)

A 61-year-old with prostatomegaly requires prostate cancer to be in the differential. Cancer of the prostate:
  • Can present with LUTS indistinguishable from BPH
  • May cause haematuria or PR bleeding if locally advanced (rectal invasion)
  • DRE findings differ: cancer feels hard, nodular, irregular vs. the firm, rubbery, smooth BPH prostate
  • PSA is the key screening test; however, PSA is also elevated by BPH and prostatitis

3. Colorectal / Anorectal Pathology

PR bleeding in a 61-year-old man is colorectal cancer until proven otherwise. This must be investigated independently of the urological picture. Causes include:
  • Haemorrhoids (most common, often secondary to straining from obstructive LUTS)
  • Anal fissure
  • Colorectal polyps or adenocarcinoma
  • Diverticular disease

4. Additional Considerations

ConditionRelevance
Bladder carcinomaPyuria + haematuria in a 61-year-old warrants cystoscopy
Bladder calculiSecondary to chronic urinary retention in BPH
Chronic bacterial prostatitisMay present with pyuria + irritative LUTS without systemic features
Urethral strictureCan cause BOO mimicking BPH

INVESTIGATIONS

Immediate Workup

TestPurpose
Urine routine/microscopyQuantify WBCs, RBCs, casts, bacteria
Urine culture & sensitivityIdentify organism, guide antibiotic choice
Urine cytologyScreen for urothelial malignancy
PSA (serum)Prostate cancer screening; interpret cautiously - elevated in BPH, prostatitis
DRE (digital rectal examination)Assess prostate size, consistency, symmetry, tenderness; identify rectal pathology
Serum creatinine / eGFRAssess for obstructive nephropathy
CBCLeukocytosis supports acute infection/prostatitis; anaemia from chronic bleeding
Blood glucoseDiabetics are predisposed to complicated UTIs
Coagulation screenIf significant or recurrent bleeding

Urological Workup

TestPurpose
Ultrasound KUB (renal tract)Prostate volume, post-void residual (PVR), hydronephrosis, bladder wall thickness, calculi
UroflowmetryObjective measure of flow rate; peak flow <10 mL/s confirms obstruction
IPSS questionnaireQuantifies symptom severity (mild 0-7, moderate 8-19, severe 20-35)
TRUS (transrectal ultrasound)Accurate prostate volume; guide for biopsy if needed
Prostate biopsyIf PSA elevated or DRE suspicious - to exclude/confirm carcinoma
CystoscopyIndicated if haematuria persists; evaluates bladder, urethra, prostate
CT urogramIf upper tract pathology or urothelial malignancy suspected
Per Bailey & Love's Surgery (Ch. 83): "All patients should have DRE to evaluate prostate size and consistency, urine culture to exclude infection, and urine cytology. PSA testing should be discussed in men with 10-15 year life expectancy to assess prostate cancer risk. Those with visible haematuria should undergo CT urogram and cystoscopy."

Colorectal Workup

  • Proctoscopy - bedside assessment of anorectal pathology (haemorrhoids, fissure)
  • Sigmoidoscopy / Colonoscopy - mandatory to exclude colorectal malignancy in a 61-year-old with PR bleeding

MANAGEMENT

Step 1: Treat Active Infection - UTI / Acute Bacterial Prostatitis

The 80-cell pyuria demands immediate treatment. Choice depends on severity:
Mild-to-moderate (outpatient):
  • Fluoroquinolones are first-line - excellent prostatic tissue penetration
    • Ciprofloxacin 500 mg BD or Levofloxacin 500 mg OD
    • Duration: 4-6 weeks (to sterilise prostatic tissue and prevent progression to chronic prostatitis/abscess)
  • Alternative: Trimethoprim-sulfamethoxazole 160/800 mg BD x 6 weeks
Severe (sepsis, urinary retention, immunocompromised) - hospitalise:
  • IV ampicillin 2 g q6h + gentamicin 1.5 mg/kg q8h until afebrile, then
  • Oral fluoroquinolone to complete 6-week course
(Goldman-Cecil Medicine, Ch. 114; Smith & Tanagho's General Urology)
Important: Avoid urethral catheterisation in acute prostatitis (risk of bacteraemia). If retention occurs, use suprapubic catheter. Avoid prostate massage in acute phase.
If culture shows fluoroquinolone resistance (especially post-TRUS biopsy), use local antibiogram to direct therapy.

Step 2: Medical Management of BPH (once infection controlled)

Per AUA BPH Guidelines 2023 and textbook evidence:
A. Alpha-1 Adrenergic Blockers (first-line for symptom relief)
  • Tamsulosin 0.4 mg OD (uroselective, preferred)
  • Alfuzosin 10 mg OD / Silodosin 8 mg OD
  • Mechanism: relax smooth muscle of prostate and bladder neck
  • Onset of action: within days-weeks
  • Side effects: orthostatic hypotension, dizziness, retrograde ejaculation (silodosin), floppy iris syndrome (discontinue before cataract surgery)
B. 5-Alpha Reductase Inhibitors (for enlarged prostates, to reduce volume and disease progression)
  • Finasteride 5 mg OD or Dutasteride 0.5 mg OD (dutasteride is preferred per Goldman-Cecil)
  • Mechanism: block conversion of testosterone to dihydrotestosterone - reduce prostate volume by 20-30% over 3-6 months
  • Benefits: reduce acute urinary retention risk and need for surgery
  • Side effects: erectile dysfunction, reduced libido, decreased ejaculate
  • PSA halved by these drugs - double the PSA result to get "true" value when screening for cancer
C. Combination therapy (superior to monotherapy for moderate-severe BPH):
  • Alpha-blocker + 5-ARI = best combination
  • Addition of tadalafil (PDE5 inhibitor) to alpha-blocker also improves symptoms
  • If storage/OAB symptoms persist: add antimuscarinic (tolterodine, solifenacin) or beta-3 agonist (mirabegron)
(Goldman-Cecil Medicine, Ch. 114)
D. Lifestyle modifications:
  • Fluid restriction (~2 L/day)
  • Reduce caffeine, alcohol, carbonated beverages
  • Timed voiding; double voiding
  • Treat constipation (worsens BOO and haemorrhoids)

Step 3: Surgical Management of BPH (when medically refractory or complications arise)

Absolute indications for surgery:
  • Acute urinary retention (refractory)
  • Recurrent UTI
  • Recurrent haematuria
  • Bladder calculi
  • Obstructive nephropathy (azotaemia, hydronephrosis)
  • Medical therapy failure with bothersome symptoms
Surgical options (Sabiston / Goldman-Cecil):
ProcedureNotes
TURP (Transurethral Resection of Prostate)Gold standard; monopolar or bipolar; bipolar uses saline - eliminates dilutional hyponatremia
Laser enucleation (HoLEP / ThuLEP)For large prostates; excellent long-term outcomes
PVP (Photoselective Vaporisation)Good for anticoagulated patients
Prostatic urethral lift (UroLift)For prostates <80g, no median lobe; preserves ejaculation
Open simple prostatectomyFor very large glands (>80-100g)
Prostatic artery embolisationEmerging; data still limited

Step 4: Investigate and Manage PR Bleeding

  • Proctoscopy to identify haemorrhoids / fissures
  • Colonoscopy is mandatory - exclude colorectal cancer
  • Haemorrhoids: conservative first (high-fibre diet, stool softeners, sitz baths, topical agents); rubber band ligation or haemorrhoidectomy if severe
  • If colorectal cancer found: refer colorectal surgery

SUMMARY FLOWCHART

61M | Prostatomegaly + PR Bleeding + Pyuria (80/HPF)
         |
         ├── URINE C&S → Antibiotics (fluoroquinolone 4-6 wks)
         |
         ├── PSA + DRE → If abnormal → TRUS biopsy → Exclude Ca prostate
         |
         ├── USS KUB + Uroflowmetry + IPSS → Grade BPH severity
         |
         ├── BPH Medical Rx → Alpha-blocker ± 5-ARI ± tadalafil
         |
         ├── Persistent haematuria → Cystoscopy + CT urogram
         |
         └── PR Bleeding → Proctoscopy + Colonoscopy → Exclude colorectal Ca

KEY CLINICAL POINTS

  1. Do not attribute everything to BPH - prostate cancer must be excluded with PSA + DRE at every age
  2. Treat infection before any prostate surgery - operating on infected prostate risks bacteraemia and sepsis
  3. PR bleeding in a 61-year-old = colorectal cancer until proven otherwise - urological and colorectal workup are independent obligations
  4. PSA is unreliable during active prostatitis - repeat 6-8 weeks after infection resolves before interpreting for cancer screening
  5. 5-ARIs halve PSA - always double the PSA value when a patient is on finasteride/dutasteride to get the true cancer risk estimate
  6. 80 pus cells/HPF is marked pyuria - this is not a borderline finding; treat aggressively and culture to guide therapy
Sources: Goldman-Cecil Medicine (Ch. 114 - BPH; Ch. 114 - Prostatitis); Smith & Tanagho's General Urology 19e (Ch. 14 - Prostatitis); Textbook of Family Medicine 9e (Ch. 40 - Prostatitis); Bailey & Love's Surgery 28e (Ch. 83 - Haematuria); AUA BPH Guideline 2023 (Sandhu JS et al., J Urol 2024;211[1]:11-19)

Best time to give tamdura tablet

Finding Sources
Searching the Web

Tamdura tablet tamsulosin dutasteride best time to take dosing instructions

Tamdura Tablet - Best Time to Take

Tamdura = Dutasteride 0.5 mg + Tamsulosin 0.4 mg (combination for BPH)

The Answer: 30 minutes after the same meal, every day

This is confirmed by Mayo Clinic, WebMD, and the FDA DailyMed label.

Why After a Meal?

  • Tamsulosin component: Taking it with food slows absorption slightly, reduces peak plasma concentration spikes, and significantly lowers the risk of orthostatic hypotension (sudden drop in BP on standing - causing dizziness, falls)
  • Dutasteride component: Relatively unaffected by food, but taking it after a meal improves GI tolerance
  • Taking on an empty stomach is specifically discouraged - it increases side effects without improving efficacy

Morning vs. Evening - Which Meal?

TimingProsCons
After breakfast (preferred by many)Easy to remember; side effects monitored during active hoursMinor dizziness risk during the day
After dinner/evening mealOrthostatic hypotension occurs during sleep (less dangerous); patient lying down during peak effectMay be forgotten
Most guidelines (including the official label) give the example of "30 minutes after dinner every day." Evening dosing is often preferred because the blood pressure-lowering peak of tamsulosin occurs while the patient is supine/sleeping, reducing fall risk.

Practical Rules

  1. Consistency is more important than the specific meal - pick one meal and stick to it every day
  2. Swallow whole - do not crush, chew, or open the capsule (contents can irritate mouth/throat)
  3. Avoid alcohol - increases dizziness and hypotension risk
  4. Missed dose: Take it the same day 30 minutes after a meal. If the next day has arrived, skip it - never double up
  5. Before cataract surgery: Inform the ophthalmologist - tamsulosin causes intraoperative floppy iris syndrome (IFIS); may need to be stopped beforehand

Bottom Line

Take Tamdura once daily, 30 minutes after dinner (or any consistent meal), at the same time every day. Evening after dinner is the most commonly recommended timing to minimise dizziness during waking hours.
This is a shared conversation. Sign in to Orris to start your own chat.